Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - TOTAL LIABILITIES
Total Liabilities RARE - Ultragenyx Pharmaceutical Inc.
1.22 B
LAST VALUE
42.36%
2 YEAR CAGR
61.50%
5 YEAR CAGR
62.38%
10 YEAR CAGR